2016 Consul General Awards Dinner
This Event is Full. Please Contact the BABC Office to be added to a waiting list.
Special Recognition Presentation:
Margaret Alkek Williams Denton Cooley, MD
Event Attire: Business
About the Recipient
Pumps & Pipes is an association of Medical, Energy, Aerospace, Academic and Community professionals and leaders. Founded in 2007, our core essentials are Education, Communication and Collaboration. Its guiding principle to problem solving is exploring “The Other Guy’s Toolkit”.
Pumps & Pipes Mission:
- Provide a platform to bring together professional groups who may not otherwise have the opportunity to interact for the transfer of knowledge and technology knowhow.
- Be the leader in promoting cross-industry collaboration to solve challenging Pumps & Pipes problems.
- Help strengthen the educational offerings in Science, Technology, Engineering and Mathematics (STEM).
BABC Houston qualifies as a tax-exempt organization under Section 501 (c) (6) of the Internal Revenue Code. As such, your sponsorship is not deductible as a charitable contribution but may be deductible as an ordinary and necessary business expense depending upon your individual tax circumstances.
DOWNLOAD SPONSOR REGISTRATION FORM or register on this page to pay by credit card.
William E. Cohn, MD, is Director of the Center for Technology and Innovation; Associate Director of Laboratory Surgery Research in the Center for Cardiac Support; and Director of the Cullen Cardiovascular Research Laboratory at the Texas Heart Institute. He is also a professor of surgery at Baylor College of Medicine and an adjunct professor of Bioengineering at both Rice University and the University of Houston. From 1993-1994, Dr. Cohn first served as a Clinical Fellow in the Cardiothoracic Surgery Department at Beth Israel Deaconess Hospital in Boston, Massachusetts. He then went on to serve as a Cardiothoracic Surgeon from 1994-2004 at Beth Israel Deaconess Medical Center and Director of Minimally Invasive Cardiac Surgery at Beth Israel Hospital from 2001-2004. Dr. Cohn joined the Texas Heart Institute in 2004. From 1994-2004 Dr. Cohn served as a professor of surgery at Harvard Medical School. His major research interests include the development of new technology for decreasing the invasiveness of cardiac and vascular surgery and development of the continuous-flow totally implantable artificial heart. In 2011, Dr. Cohn and Dr. O. H. Frazier successfully implanted the first pulseless total heart replacement device in a human patient. Dr. Cohn has a passion for medical device development and has more than 90 US patents granted or pending and another 60 international patents for his medical innovations. His numerous awards include an honorary doctorate in science from Oberlin College, the Distinguished Scientist Award, given by the MacDonald Fund, and the Edison Award for excellence in human-centered design and innovation for inventing the SentreHEART® Lariat® Suture Delivery Device. In 2000, Dr. Cohn was named the distinguished Inventor of the Year by the U.S. Intellectual Property Owners Association and in 2014, he was named Outstanding Inventor of the Year by the Houston IPO. In addition, in 2014 he received an award for the most Innovative Medical Device Startup of the year at the Innovations in Cardiovascular Interventions Conference in Tel Aviv for inventing the TVA Everlin q system for percutaneous creation of AV fistulas and for founding TVA Medical. In 2015, he was awarded a Lifetime Achievement Award for healthcare innovation by the Houston Technology Center. He is a Venture Partner at Santé Health Ventures, and Chief Medical Officer of BiVACOR Inc. and Reliant Heart. Dr. Cohn graduated with a B.S from Oberlin College and his MD from Baylor College of Medicine.
From his early life, Larry Lawson was true visionary, gifted salesman and extraordinary organizer. Lawson blended these unique talents when he joined Johnson & Johnson in 1970 as a medical device salesman. He rapidly rose through the J & J corporate ladder succeeding in sales, sales management and marketing while collecting a large group of clients that trusted his vision and relied on his outstanding customer service.
A self confessed “serial entrepreneur,” Lawson could see the emerging market for top quality medical products in Latin America and the Middle East. To service this, Lawson ventured out on his own in 1980 as he created Mesco Inc., an international sales and marketing firm specializing in sales for American and European medical manufacturers, to supply developing markets throughout Latin America, Europe and Middle Eastern countries.
By 1983 Lawson’s success was obvious to German giant, Rudolph Riester GmbH., manufacturer of precision medical diagnostic instruments and devices. At their request, Lawson founded LifeMed, Inc., to be the exclusive U.S. sales, marketing and distribution for Rudolph Riester GmbH. Lawson helped them monopolize 10% of this budging market in just six years. As CEO of LifeMed, Lawson determined corporate objectives, short and long-term business plans for venture capital funding, administering operating budgets, directing overall marketing strategies and sales activities. Under Lawson’s guidance LifeMed negotiated exclusive private label agreements with national hospital/healthcare groups while developing distribution through major national medical distributors.
“Listen to the customer” has been Lawson’s key to success. While CEO of LifeMed, Lawson could see the next great market developing and changed his focus to cardiac arrhythmia monitoring services in 2000, as he founded Diagnostic Monitoring Associates. Capitalizing on relationships, Lawson’s Diagnostic Monitoring Associates, a national marketing and sales firm provided cardiac arrhythmia monitoring services to physicians throughout America. He replicated the success in his previous companies by insuring the overall sales, marketing strategies embodied his dedication to quality products and total commitment to excellence in customer service.
By 2004 Lawson created his Opus! He founded eCardio, the leading arrhythmia-monitoring company in America that providing flexible, fast and accurate diagnoses to physicians and patients world wide focusing on atrial fibrillation detection and analysis. Right place, right time with the right product and customer service, enabled eCardio’s dramatic growth and qualifying it’s ranking in the INC. 500/5000 magazine as one of the Top 500 fastest-growing companies in American from 2009 through 2012. Lawson’s business leadership was recognized as he was awarded Ernst & Young’s Health Science Entrepreneur of the Year in 2009.
More honors came as his alma mater, Lamar University in Beaumont, Texas, granted Lawson an honorary Doctor of Humane Letters 2012 for his contribution to the betterment of health of mankind through the outstanding works of eCardio. Considered a musical prodigy as a child, while a teenager Lawson was the creative force and mastermind behind the band The Clique. In 2008 he was inducted into the Gulf Coast Music Hall of Fame along side ZZ Top, Janice Joplin and The Big Bopper, J. P Richardson.
Lawson decided to take eCardio worldwide. He combined eCardio Diagnostics, the leading provider of remote cardiac monitoring products and services and Preventice, a leading software, care platforms and sensor devices to drive innovation and growth in remote monitoring systems and mobile health applications worldwide. The two companies operate as Preventice, Inc.
Larry Lawson served as chairman and chief executive officer Preventice, Inc. Lawson explained, “We have collected a powerful group of partners in this new holding company. The Preventice-eCardio combination primary stockholder is now GHIF (The Merck Global Health Innovation Fund).
Boston Scientific, global giant in medical devices, made a significant investment in Preventice in 2014 allowing Lawson to step down to form a new venture, HeartcoR Solutions, an ECG Core Lab providing 24/7 research and clinical trial management services to pharma, medical device, and biotech companies worldwide. HeartcoR Solutions is now based in Chicago but destined to move to the Texas Medical Center within two years.
2015 brought more accolades for Lawson who has been one of the key elements of the success of the first Texas Medical Center’s Accelerator class of start-ups. Lawson applies his 40+ years in successful development for medical devices ‘from concept to market’ to guide and mentor many of the 32 start-ups to financial strength. Taking the responsibility quite seriously, Lawson has become an investor and board member of several of the young start-ups.
Founder Dr. Jack Gill invited Lawson to join the 15-member GOOSE Society (Grand Order Of Successful Entrepreneurs) committed to educate, train, invest in and support entrepreneurs, as GOOSE is the force behind the world famous Rice Business Plan Competition. GOOSE boasts legendary business minds as Rod Canion, founder of Compact Computers and Dr. Nancy Chang founder of Tanox. The membership is steeped in oil & gas wisdom and welcome Lawson as the exclusive authority in medical devices.
Lawson is part of the International Committee for the 2017 Super Bowl in Houston.
Robbins joined the Texas Medical Center as president and CEO in 2012. Since then, he has significantly enhanced the institution’s commitment to collaboration, introducing five cross-institutional research initiatives centered on innovation, genomics, regenerative medicine, health policy and clinical research.
An internationally recognized cardiac surgeon, Robbins has focused his clinical efforts on acquired cardiac diseases with a special expertise in the surgical treatment of congestive heart failure. His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels and automated vascular anastomotic devices.
Prior to joining TMC, Robbins served as professor and chairman of the Department of Cardiothoracic Surgery at Stanford University School of Medicine, director of the Stanford Cardiovascular Institute, president of the International Society of Heart and Lung Transplantation, president of the Bay Area Society of Thoracic Surgeons, and chair of the American Heart Association Cardiovascular Surgery and Anesthesia Council, among other roles.
Robbins is the author of more than 292 peer-reviewed articles and a former guest editor of theCirculation Surgical Supplement. He currently sits on the advisory board of Ronald McDonald House Houston and on the board of directors for TMC, the Greater Houston Partnership, the Greater Houston Convention and Visitors Bureau, Houston Academy of Medicine, TMC Library, Houston Technology Center and Friends of Houston Academy of Medicine.
His educational background includes a B.S. in chemistry from Millsaps College (1979), medical degree from the University of Mississippi (1983), general surgical training at the University of Mississippi (1989), cardiothoracic training at Stanford University (1992), post-doctoral research at Columbia University and the National Institutes of Health, and congenital heart surgical fellowships at Emory University and Royal Children’s Hospital.